On Demand Therapeutics
Medical Devices, 699 Old Orch Dr, Danville, California, 94526, United States, 1-10 Employees
Phone Number: 30********
Who is ON DEMAND THERAPEUTICS
The Total Solution for Sight-Threatening Retinal DiseasesOn Demand Therapeutics, Inc. (ODTxTM) was formed in May 2009 as a unique joint venture between InterWest Partners, a leading diver...
Read More
-
Headquarters: 699 Old Orch Dr, Danville, California, 94526, United States
-
Date Founded: 2009
-
Employees: 1-10
-
Revenue: $250 Million to $500 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ON DEMAND THERAPEUTICS
On Demand Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding On Demand Therapeutics
Answer: On Demand Therapeutics's headquarters are located at 699 Old Orch Dr, Danville, California, 94526, United States
Answer: On Demand Therapeutics's phone number is 30********
Answer: On Demand Therapeutics's official website is https://ondemandtx.com
Answer: On Demand Therapeutics's revenue is $250 Million to $500 Million
Answer: On Demand Therapeutics's SIC: 2834
Answer: On Demand Therapeutics's NAICS: 325412
Answer: On Demand Therapeutics has 1-10 employees
Answer: On Demand Therapeutics is in Medical Devices
Answer: On Demand Therapeutics contact info: Phone number: 30******** Website: https://ondemandtx.com
Answer: The Total Solution for Sight-Threatening Retinal DiseasesOn Demand Therapeutics, Inc. (ODTxTM) was formed in May 2009 as a unique joint venture between InterWest Partners, a leading diversified venture capital firm, and MicroCHIPS, a developer of intelligent implant systems. In addition to its own intellectual property, ODTx has acquired exclusive ophthalmology rights to the extensive patent portfolio and technical expertise developed by MicroCHIPS in the areas of implantable drug delivery and monitoring devices. With its initial funding, ODTx has already demonstrated key features of the delivery technology in vivo. ODTx is now proceeding to create relationships with pharmaceutical and medical device companies interested in developing differentiated ophthalmic products based on this breakthrough drug delivery platform.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month